Stockreport

With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors [Yahoo! Finance]

Design Therapeutics, Inc.  (DSGN) 
PDF The top 6 shareholders own 53% of the company 16% of Design Therapeutics is held by insiders If you want to know who really controls Design Therapeutics, Inc. ( NAS [Read more]